TY - JOUR AU - Montolío-Marzo, S. AU - Vidal-Oliver, L. AU - Montolío-Marzo, E. AU - Dolz-Marco, R. AU - Gallego-Pinazo, R. TI - Differential diagnosis of endophthalmitis after intravitreal drug injection for age related macular degeneration: Sterile vs. infectious JF - ARCHIVOS DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA J2 - ARCH SOC ESP OFTALMOL VL - 98 PY - 2023 IS - 7 SP - 367 EP - 376 PG - 10 SN - 0365-6691 DO - 10.1016/j.oftal.2023.04.004 UR - https://m2.mtmt.hu/api/publication/34501300 ID - 34501300 N1 - Clínica Oftalvist, Valencia, Spain FISABIO Oftalmología Médica, Valencia, Spain Hospital Clínico Universitario San Carlos, Madrid, Spain Export Date: 14 January 2024 CODEN: ASEOA Correspondence Address: Montolío-Marzo, S.; Clínica OftalvistSpain; email: s.montoliomarzo@gmail.com LA - Spanish DB - MTMT ER - TY - JOUR AU - Dorronsoro, M. AU - Bronfen, S. AU - Alconcher, L. AU - Lucarelli, L. TI - Bilateral neuroretinitis and membranous lupus nephritis: 2 infrequent manifestations in juvenile lupus JF - ARCHIVOS DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA J2 - ARCH SOC ESP OFTALMOL VL - 98 PY - 2023 IS - 3 SP - 175 EP - 179 PG - 5 SN - 0365-6691 DO - 10.1016/j.oftal.2022.12.003 UR - https://m2.mtmt.hu/api/publication/34183318 ID - 34183318 N1 - Export Date: 9 October 2023 CODEN: ASEOA LA - Spanish DB - MTMT ER - TY - JOUR AU - Ciprés, M. AU - Satue, M. AU - Melchor, I. AU - Gil-Arribas, L. AU - Vilades, E. AU - Garcia-Martin, E. TI - Retinal neurodegeneration in patients with type 2 diabetes mellitus without diabetic retinopathy JF - ARCHIVOS DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA J2 - ARCH SOC ESP OFTALMOL VL - 97 PY - 2022 IS - 4 SP - 205 EP - 218 PG - 14 SN - 0365-6691 DO - 10.1016/j.oftal.2021.04.004 UR - https://m2.mtmt.hu/api/publication/32790553 ID - 32790553 N1 - Servicio de Oftalmología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain Servicio de Oftalmología, Hospital Universitario Miguel Servet, Zaragoza, Grupo de investigación Miguel Servet Oftalmología (GIMSO), Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Universidad de Zaragoza, Zaragoza, Spain Departamento de Endocrinología, Hospital Universitario Miguel Servet, Zaragoza, Spain Export Date: 22 April 2022 CODEN: ASEOA Correspondence Address: Ciprés, M.; Servicio de Oftalmología, Spain; email: martacipres90@gmail.com AB - In diabetes mellitus (DM) patients retinal complications were typically considered part of a vascular process. Recent research suggests that retinal degeneration in DM might also be caused by a neuropathy that could precede microvascular alterations. The present work reviews the currently available bibliography about neurodegeneration in patients with type 2 DM (DM2) without diabetic retinopathy (DR). In patients with non-severe, early DM2 without DR and good metabolic control visual function parameters show early abnormalities that precede clinical DR (in which we diagnose with a conventional ophthalmological examination). Using optical coherence tomography (OCT) technology, a reduction in macular and peripapillary thickness has been observed in different studies. Recent researches suggest that systemic complications (especially ischaemia) and a possible microvascular alteration eventually contributes to retinal neurodegeneration, which opens the door to new studies that include new techniques for evaluating the microvascularization of the retinal layers. © 2022 Sociedad Española de Oftalmología LA - Spanish DB - MTMT ER - TY - JOUR AU - Fonollosa, A. AU - Gallego-Pinazo, R. AU - Sararols, L. AU - Adán, A. AU - López-Gálvez, M. AU - Figueroa, M.S. TI - Guidance on brolucizumab management recommendations JF - ARCHIVOS DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA J2 - ARCH SOC ESP OFTALMOL VL - 97 PY - 2022 IS - 11 SP - 626 EP - 638 PG - 13 SN - 0365-6691 DO - 10.1016/j.oftal.2022.02.006 UR - https://m2.mtmt.hu/api/publication/34124849 ID - 34124849 N1 - Servicio de Oftalmología, Hospital Universitario de Cruces, Vizcaya, Barakaldo, Spain Instituto Oftalmológico Bilbao, Bilbao, Spain Unidad de Mácula y Ensayos Clínicos, Clínica Oftalvist, Valencia, Spain Servicio de Oftalmología, Hospital General de Granollers, Barcelona, Granollers, Spain Servicio de Oftalmología, Hospital Universitario General de Cataluña, Barcelona, Sant Cugat del Vallès, Spain Institut Clínic d'Oftalmologia (ICOF), Hospital Clínic, Barcelona, Spain Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Barcelona, Spain Servicio de Oftalmología, Hospital Clínico Universitario de Valladolid, Valladolid, Spain Instituto de Oftalmobiología Aplicada (IOBA), Universidad de Valladolid, Valladolid, Spain Unidad de Retina, Clínica Baviera, Madrid, Spain Servicio de Oftalmología, Hospital Universitario Ramón y Cajal, Madrid, Spain Cited By :3 Export Date: 4 September 2023 CODEN: ASEOA Correspondence Address: López-Gálvez, M.; Servicio de Oftalmología, Spain; email: maribel@ioba.med.uva.es AB - Purpose: Brolucizumab, a new generation anti-VEGF, has demonstrated efficacy and safety in AMD in the pivotal HAWK and HARRIER trials. Post-marketing, previously undetected adverse events related to intraocular inflammation have been reported. An independent post hoc review of the pivotal trials puts the rate of intraocular inflammation (IOI) at 4.6%. The aim of this paper is to propose a set of recommendations for implementing the management of brolucizumab in clinical practice. Method: The recommendations made by the authors are based on their clinical experience and critical review of (i) the pivotal trials; (ii) the post-hoc analysis of the Safety Review Committee, and (iii) the published literature. Results: In the pivotal trials, brolucizumab showed sustained functional gains, superior anatomical outcomes with potentially longer intervals between injections and a well-tolerated overall safety profile. Adverse events reported post-marketing include retinal vasculitis and retinal vascular occlusion. Based on the available information, experts recommend (i) ruling out non-recommended patient profiles (prior history of ORI); (ii) screening the patient prior to each injection to rule out active IOI; (iii) monitoring the patient for early warning signs, and (iv) treating immediately should any adverse events develop. Conclusions: The adverse events reported are rare, but may be associated with severe and irreversible loss of visual acuity. The recommendations made are intended to facilitate the management of brolucizumab in the routine practice of retinologists, to ensure patient safety and, should any adverse events occur, to minimise their impact on vision. © 2022 The Author(s) LA - Spanish DB - MTMT ER - TY - JOUR AU - Asensio-Sánchez, V.M. AU - Pacheco-Callirgos, G.E. AU - Valentín-Bravo, J. AU - García-Onrubia, L. TI - Visual acuity loss and sixth nerve palsy as the only manifestations of slit ventricle syndrome JF - ARCHIVOS DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA J2 - ARCH SOC ESP OFTALMOL PY - 2021 SN - 0365-6691 DO - 10.1016/j.oftal.2020.11.016 UR - https://m2.mtmt.hu/api/publication/31919377 ID - 31919377 N1 - Export Date: 17 March 2021 CODEN: ASEOA Correspondence Address: Asensio-Sánchez, V.M.; Servicio de Oftalmología, Spain; email: vmasensio@yahoo.esvictor AB - The case is presented of a girl diagnosed with obstructive hydrocephalus due to pilomyxoid astrocytoma, which required a ventriculoperitoneal shunt (VPS) at the age of 5 years and 10 months. Two months later, magnetic resonance imaging of the brain did not show ventriculomegaly or other signs of increased intracranial pressure. At the age of 6 years and 2 months, a rapid onset of bilateral visual acuity loss developed and she was diagnosed with slit ventricle syndrome. Despite valve revisions of the VPS, she developed an abrupt decline of visual acuity to hand motion at 10 cm. Fundus examination revealed bilateral optic atrophy. She did not report any other systemic symptoms suggesting increased intracranial pressure, such as headache, nausea, vomiting, lethargy, irritability, or altered levels of consciousness. © 2020 Sociedad Española de Oftalmología LA - Spanish DB - MTMT ER - TY - JOUR AU - Fernández-Vigo, J.I. AU - Burgos-Blasco, B. AU - Calvo-González, C. AU - Escobar-Moreno, M.J. AU - Shi, H. AU - Jiménez-Santos, M. AU - Valverde-Megías, A. AU - Reche-Frutos, J. AU - López-Guajardo, L. AU - Donate-López, J. TI - Assessment of vision-related quality of life and depression and anxiety rates in patients with neovascular age-related macular degeneration JF - ARCHIVOS DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA J2 - ARCH SOC ESP OFTALMOL VL - 96 PY - 2021 IS - 9 SP - 470 EP - 475 PG - 6 SN - 0365-6691 DO - 10.1016/j.oftal.2020.11.010 UR - https://m2.mtmt.hu/api/publication/31896128 ID - 31896128 LA - Spanish DB - MTMT ER - TY - JOUR AU - Herranz-Heras, J.C. AU - Alcalde-Blanco, L. AU - Cañas-Zamarra, I. AU - Mencía-Gutiérrez, E. AU - Ferro-Osuna, M. AU - Pérez-Trigo, S. TI - Update on the perioperative management of antiplatelets and anticoagulants in ophthalmic surgery JF - ARCHIVOS DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA J2 - ARCH SOC ESP OFTALMOL VL - 96 PY - 2021 IS - 8 SP - 422 EP - 429 PG - 8 SN - 0365-6691 DO - 10.1016/j.oftal.2020.11.006 UR - https://m2.mtmt.hu/api/publication/32776294 ID - 32776294 N1 - Export Date: 7 April 2022 CODEN: ASEOA Correspondence Address: Herranz-Heras, J.C.; Servicio de Oftalmología, Spain; email: jc.herranzh@gmail.com LA - Spanish DB - MTMT ER - TY - JOUR AU - Vidal-Villegas, B. AU - Gallego-Ortega, A. AU - Miralles de Imperial-Ollero, J.A. AU - Martínez de la Casa, J.M. AU - García Feijoo, J. AU - Vidal-Sanz, M. TI - Células ganglionares fotosensibles: una población diminuta pero esencial JF - ARCHIVOS DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA J2 - ARCH SOC ESP OFTALMOL VL - 96 PY - 2021 IS - 6 SP - 299 EP - 315 PG - 17 SN - 0365-6691 DO - 10.1016/j.oftal.2020.06.032 UR - https://m2.mtmt.hu/api/publication/32052884 ID - 32052884 LA - English DB - MTMT ER - TY - JOUR AU - Moreno-Morillo, F.J. AU - Fernández-Vigo, J.I. AU - Güemes-Villahoz, N. AU - Burgos-Blasco, B. AU - López-Guajardo, L. AU - Donate-López, J. TI - Update on the management of chronic central serous chorioretinopathy JF - ARCHIVOS DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA J2 - ARCH SOC ESP OFTALMOL VL - 96 PY - 2021 IS - 5 SP - 251 EP - 264 PG - 14 SN - 0365-6691 DO - 10.1016/j.oftal.2020.07.023 UR - https://m2.mtmt.hu/api/publication/31854391 ID - 31854391 N1 - Departamento de Oftalmología, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria (IdISSC), Madrid, Spain Centro Internacional de Oftalmología Avanzada, Madrid, Spain Export Date: 8 February 2021 CODEN: ASEOA Correspondence Address: Fernández-Vigo, J.I.; Departamento de Oftalmología, Spain; email: jfvigo@hotmail.com Departamento de Oftalmología, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria (IdISSC), Madrid, Spain Centro Internacional de Oftalmología Avanzada, Madrid, Spain Export Date: 18 September 2021 CODEN: ASEOA Correspondence Address: Fernández-Vigo, J.I.; Departamento de Oftalmología, Spain; email: jfvigo@hotmail.com LA - Spanish DB - MTMT ER - TY - JOUR AU - Bilbao-Calabuig, R. AU - Gónzalez-López, F. AU - Llovet-Rausell, A. AU - Ortega-Usobiaga, J. AU - Tejerina, Fernández V. AU - Llovet-Osuna, F. TI - Lens-based surgical correction of presbyopia. Where are we in 2020? JF - ARCHIVOS DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA J2 - ARCH SOC ESP OFTALMOL VL - 96 PY - 2021 IS - 2 SP - 74 EP - 88 PG - 15 SN - 0365-6691 DO - 10.1016/j.oftal.2020.07.012 UR - https://m2.mtmt.hu/api/publication/31850784 ID - 31850784 N1 - Unidad de Cirugía Refractiva y Cataratas, Clínica Baviera-Aier Hospital Eye Group, Madrid, Spain Unidad de Cirugía Refractiva y Cataratas, Clínica Baviera-Aier Hospital Eye Group, Valencia, Spain Unidad de Cirugía Refractiva y Cataratas, Clínica Baviera-Aier Hospital Eye Group, Bilbao, Spain Servicio Oftalmología, Hospital Universitario La Fe, Valencia, Spain Export Date: 5 February 2021 CODEN: ASEOA Correspondence Address: Bilbao-Calabuig, R.; Unidad de Cirugía Refractiva y Cataratas, Spain; email: rbilbao@clinicabaviera.com Unidad de Cirugía Refractiva y Cataratas, Clínica Baviera-Aier Hospital Eye Group, Madrid, Spain Unidad de Cirugía Refractiva y Cataratas, Clínica Baviera-Aier Hospital Eye Group, Valencia, Spain Unidad de Cirugía Refractiva y Cataratas, Clínica Baviera-Aier Hospital Eye Group, Bilbao, Spain Servicio Oftalmología, Hospital Universitario La Fe, Valencia, Spain Export Date: 16 September 2021 CODEN: ASEOA Correspondence Address: Bilbao-Calabuig, R.; Unidad de Cirugía Refractiva y Cataratas, Spain; email: rbilbao@clinicabaviera.com LA - Spanish DB - MTMT ER -